Clinical Trial Update: CFI-400945 in Patients With Advanced/Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of CFI-400945 for advanced or metastatic breast cancer is ongoing, with the trial currently listed as ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CFI-400945 (CFI-400945)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING